TrialInternational journal of hematology2013
Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin's lymphoma.
Seon-Kyeong Kim et al.PubMed ↗Publisher ↗
No numbers read from the abstract.